Drug intelligence / Profile preview

ibuprofen + tramadol

Development stage
Unknown
Lead developer
FARMALIDER
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ibuprofen + tramadol is a fixed-dose combination analgesic being developed for the management of acute severe postoperative pain. This combination utilizes a multimodal approach to pain management, combining the anti-inflammatory and peripheral analgesic effects of ibuprofen with the centrally acting analgesic properties of tramadol. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis. Tramadol acts as a mu-opioid receptor agonist and also inhibits the reuptake of serotonin and norepinephrine, enhancing descending inhibitory pain pathways. The specific formulation under development by Farmalider S.A. is an intravenous (IV) solution containing ibuprofen arginate (to enhance solubility) and tramadol hydrochloride, intended for use in adults undergoing surgery to provide effective analgesia while potentially reducing the overall requirement for higher-dose opioid monotherapy.

Brand names
Argetram
Other names
ibuprofen (arginate) + tramadol hydrochlorideIV ibuprofen + tramadol
02

Targets

MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ibuprofen + tramadol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + tramadol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call